Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis

March 2019 in “ Dermatologic surgery ”

Poonkiat Suchonwanit, Nongsak Chanasumon, Tueboon Sriphojanart

bimatoprost eyebrow hypotrichosis placebo Latisse

Studysummary In this randomized trial, bimatoprost 0.01% significantly improved eyebrow hair density and diameter in patients with eyebrow hypotrichosis compared to a placebo, with minimal adverse effects, suggesting it is an effective and safe treatment option. Our plain-language summary of this paper — not a Tressless recommendation.

A randomized, double-blinded, vehicle-controlled trial involving 40 patients evaluated the efficacy and safety of bimatoprost 0.01% for treating eyebrow hypotrichosis over 6 months. The study found that bimatoprost 0.01% significantly increased eyebrow hair density, diameter, and clinical assessments compared to the placebo (p < .001). Patients reported higher satisfaction with bimatoprost (p < .05), and adverse effects were minimal and similar between groups. The study concluded that bimatoprost 0.01% is effective, safe, and well-tolerated for enhancing eyebrows.

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Therapeutic Potential of Bimatoprost for the Treatment of Eyebrow Hypotrichosis

34 citations , February 2018 in “Drug Design Development and Therapy”

This source reports that bimatoprost, a medication approved for eyelash growth, has shown efficacy in treating eyebrow hypotrichosis, suggesting it as a noninvasive, effective, and well-tolerated option for enhancing eyebrow hair.

research Treatment of Eyebrow Hypotrichosis Using Bimatoprost: A Randomized, Double-Blind, Vehicle-Controlled Pilot Study

22 citations , April 2013 in “Dermatologic surgery”

In this study, daily application of bimatoprost 0.03% ophthalmic solution for 9 months significantly improved eyebrow appearance in individuals with mild to moderate eyebrow hypotrichosis, without observed side effects.

Efficacy and Safety of Bimatoprost 0.03% Versus Minoxidil 3% in Enhancement of Eyebrows: A Randomized, Double-Blind, Split-Face Comparative Study

research Efficacy and Safety of Bimatoprost 0.03% Versus Minoxidil 3% in Enhancement of Eyebrows: A Randomized, Double-Blind, Split-Face Comparative Study

17 citations , May 2012 in “Journal of dermatology”

This letter to the editor compares the efficacy and safety of bimatoprost 0.03% with minoxidil 3% for eyebrow enhancement but does not report any study results.

research Eyelash Growth from Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes

29 citations , May 2010 in “Ophthalmology”

Bimatoprost gel makes eyelashes grow longer, but may cause side effects and should be monitored by an eye doctor.

research Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth

69 citations , April 2010 in “Dermatologic Surgery”

This review discusses the safety and efficacy of bimatoprost ophthalmic solution 0.03% for enhancing eyelash growth by influencing the eyelash hair cycle and follicles, and it reports no new results.

research Bimatoprost in the Treatment of Eyelash Hypotrichosis

69 citations , April 2010 in “Clinical ophthalmology”

This article reviews the use of bimatoprost for eyelash hypotrichosis and reports its effectiveness in promoting eyelash growth but highlights uncertain efficacy in cases of eyelash alopecia areata.

research Management of Hypotrichosis of the Eyelashes: Focus on Bimatoprost

23 citations , April 2010 in “Clinical, cosmetic and investigational dermatology”

This review discusses the cutaneous application of bimatoprost ophthalmic solution 0.03% for enhancing upper eyelash growth and suggests it is both safe and effective; no new clinical results are reported.

research Successful Use of Bimatoprost in the Treatment of Eyelash Alopecia

15 citations , November 2009 in “Clinical and Experimental Dermatology”

This case study describes a 16-year-old girl with alopecia areata affecting her eyelashes and eyebrows, who showed very limited response to treatment with topical mometasone furoate and subsequent partial hair loss upon stopping the treatment.

research Eyebrow Loss

29 citations , January 2007 in “American Journal of Clinical Dermatology”

This article reviews the social and functional impact of eyebrow loss and highlights the limited treatment options compared to scalp alopecia, but reports no new clinical results.

research Madarosis

33 citations , November 2006 in “Survey of Ophthalmology”

This report discusses the various causes and clinical assessment of madarosis, emphasizing the importance of recognizing and diagnosing associated vision or life-threatening conditions, without presenting new findings.